Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy

Christian Breymann, Eva Visca, Renate Huch, Albert Huch

Open source

DOI
10.1067/mob.2001.111717
Published
2001-03
Container
American Journal of Obstetrics and Gynecology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mob.2001.111717,
  title = {Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy},
  author = {Christian Breymann and Eva Visca and Renate Huch and Albert Huch},
  year = {2001},
  journal = {American Journal of Obstetrics and Gynecology},
  doi = {10.1067/mob.2001.111717},
  url = {https://doi.org/10.1067/mob.2001.111717}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy
AU  - Christian Breymann
AU  - Eva Visca
AU  - Renate Huch
AU  - Albert Huch
PY  - 2001
JO  - American Journal of Obstetrics and Gynecology
DO  - 10.1067/mob.2001.111717
UR  - https://doi.org/10.1067/mob.2001.111717
ER  - 

APA

Breymann, C., Visca, E., Huch, R., & Huch, A. (2001). Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. American Journal of Obstetrics and Gynecology. https://doi.org/10.1067/mob.2001.111717

Source records